IDEX Biometrics ASA - Share Issue/Capital Change 2017

Mandatory notification of trades in IDEX

On 24 February 2017, Dr. Hemant Mardia, primary insider and CEO of IDEX,

exercised 5,000,000 subscription rights that were granted to him under the

company's 2013 incentive subscription rights plan and acquired the corresponding

number of shares at a weighted average price of NOK 1.69 per share. To fund the

exercise and tax amounts, Dr. Mardia sold 3,250,000 shares at a price of NOK

6.00 per share on the same day. Following these transactions, Dr. Mardia and his

close associates hold or control 2,115,625 shares and 3,250,000 subscription

rights in IDEX.

On 24 February 2017, Fred Benkley, primary insider and CTO of IDEX, was granted

750,000 subscription rights under the company's 2016 incentive subscription

rights plan. The exercise price of the subscription rights is NOK 6.59 per

share. 25 % of the subscription rights vest on each anniversary from the date of

the grant. The subscription rights expire on 11 May 2021. In addition, the Board

resolved to extend the duration of 500,000 subscription rights granted to Mr.

Benkley in 2013, from 23 September 2017 until 16 May 2018. Following these

transactions, Mr. Benkley and close associates hold or control 0 (nil) shares

and 1,600,000 subscription rights in IDEX.

24 February 2017

IDEX ASA

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

AI assistant